Analyses on the Clinical Usefulness of Natural Killer Cell Activity in Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Choi, Sue In [1 ]
In, Kwnag Ho [1 ]
Kang, Kyung Ho [1 ]
Shim, Jae Jeong [1 ]
Shin, Chol [1 ]
Lee, Sang Yeub [1 ]
Kim, Je Hyeong [1 ]
Lee, Sung Yong [1 ]
Lee, Seung Heon [1 ]
Hur, Gyu Young [1 ]
Min, Kyung Hoon [1 ]
Lee, Eun Joo [1 ]
Jung, Won Jai [1 ]
机构：
[1] Korea Univ, Seoul, South Korea
来源：
CHEST | 2017年 / 152卷 / 04期
关键词：
D O I：
10.1016/j.chest.2017.08.693
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：663A / 663A
页数：1
相关论文
共 50 条
  • [21] Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer
    Gemelli, Maria
    Noonan, Douglas M.
    Carlini, Valentina
    Pelosi, Giuseppe
    Barberis, Massimo
    Ricotta, Riccardo
    Albini, Adriana
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] The clinical significance of autophagy in patients with non-small cell lung cancer
    Nakashima, Nariyasu
    Liu, Dage
    Nakano, Takayuki
    Go, Tetsuhiko
    Yokomise, Hiroyasu
    CANCER SCIENCE, 2018, 109 : 1425 - 1425
  • [23] Abnormal expression and clinical significance of surface receptors on natural killer cells in the peripheral blood of patients with non-small cell lung cancer
    Liu, Peng-Cheng
    Feng, Xiao-Wen
    Zhao, Xiao-Min
    Ye, Jing
    He, Feng-Lian
    Liu, Hui
    Li, Ren-Ming
    Wang, Xue-Fu
    Zhao, Da-Hai
    NEOPLASMA, 2022, 69 (04) : 931 - 939
  • [24] Usefulness of denosumab to nonsquamous non-small cell lung cancer patients with bone metastases
    Udagawa, Hibiki
    Niho, Seiji
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Ohmatsu, Hironobu
    Goto, Koichi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Telomerase activity in non-small cell lung cancer
    Dobija-Kubica, Katarzyna
    Zalewska-Ziob, Marzena
    Brulinski, Krzysztof
    Rogozinski, Pawel
    Wiczkowski, Andrzej
    Gawrychowska, Agata
    Gawrychowski, Jacek
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2016, 13 (01): : 15 - 20
  • [26] CLINICAL USEFULNESS OF PULMONARY FUNCTION TEST IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER RECEIVING CHEMOTHERAPY
    Lee, S. H.
    Ha, J. H.
    Yeo, C. D.
    Park, K. H.
    Park, C. K.
    Kim, J. S.
    Kim, M. S.
    Kim, S. S.
    Kim, S. J.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S75 - S75
  • [27] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
    Ramírez, JL
    Sancho, E
    Núñez, L
    Sánchez, JJ
    Balañá, C
    López, P
    Martín, C
    Monzó, M
    Rosell, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S39 - S39
  • [28] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
    Pifarre, A
    Monzo, M
    Martin, C
    Sanchez, JJ
    Barnadas, A
    Rosell, R
    ANNALS OF ONCOLOGY, 1998, 9 : 92 - 92
  • [29] ASSESSING THE HEALTHCARE COST OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A428 - A428
  • [30] Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer
    Zucchetti, M
    Pagani, O
    Torri, V
    Sessa, C
    DIncalci, M
    DeFusco, M
    deJong, J
    Gentili, D
    Martinelli, G
    Tinazzi, A
    Cavalli, F
    CLINICAL CANCER RESEARCH, 1995, 1 (12) : 1517 - 1524
12345